Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein kinase CK2

L A Pinna1

  • 1Dipartimento di Chimca Biologica, Università di Padova, Italy.

The International Journal of Biochemistry & Cell Biology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Protein kinase CK2, crucial for cell signaling, is overexpressed in cancers. Inhibitors targeting this kinase show promise for treating leukemia and other neoplastic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases.

Biochemistry. Biokhimiia·2018
Same author

Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases.

BioTechniques·2015
Same author

A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.

Cellular and molecular life sciences : CMLS·2014
Same author

Kinase CK2 inhibition: an update.

Current medicinal chemistry·2012
Same author

Investigation on PLK2 and PLK3 substrate recognition.

Biochimica et biophysica acta·2012
Same author

Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways.

Leukemia·2012
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein kinase CK2 (CK2) is a vital enzyme involved in phosphorylating proteins with acidic residues.
  • CK2 plays a role in regulating key cellular processes, including enzyme activity, growth factor signaling, and gene transcription.
  • The CK2 holoenzyme comprises catalytic and regulatory subunits, with its activity influenced by interactions with proteins like HSP90 and p53.

Purpose of the Study:

  • To elucidate the role of Protein kinase CK2 in cellular functions.
  • To investigate the association of CK2 with other cellular proteins.
  • To explore the therapeutic potential of CK2 inhibitors in neoplastic diseases.

Main Methods:

  • Characterization of the CK2 holoenzyme structure and subunit interactions.

Related Experiment Videos

  • Analysis of CK2 activity in various cellular contexts.
  • Evaluation of CK2 expression levels in proliferating and neoplastic tissues.
  • Assessment of disease development in CK2-overexpressing mouse models.
  • Development and testing of specific CK2 inhibitors.

    • Main Results:

    • CK2 phosphorylates a wide range of substrates, including enzymes, receptors, and transcription factors.
    • CK2 is constitutively active and its localization is modulated by protein interactions.
    • Abnormal elevation of CK2 is observed in proliferating and cancerous tissues.
    • Mice overexpressing CK2 exhibit a predisposition to developing leukemia.

    Conclusions:

    • Protein kinase CK2 is a significant regulator of cellular processes.
    • Dysregulation of CK2 is implicated in cancer development, particularly leukemia.
    • Targeting CK2 with specific inhibitors represents a promising therapeutic strategy for cancer treatment.